Alternative and Adjunctive Approaches for High-Risk Patients For patients with significant pancreatitis history, lifestyle modifications remain the foundation of weight loss
These data indicate that in addition to limitations in expression of the ETC-OXPHOS system, SC-islets exhibit robust differences in mitochondrial fatty acid metabolism compared to primary human islets
A Multi-Pathway Model We can think of this as a convergence of several mechanisms: L-cell activation from viral or microbial sensing Vagal signaling altered by cytokine release Gut-brain axis dysregulation, mirroring GLP-1 agonist effects Delayed motility from enteric nervous system inflammation Together, these pathways could produce a temporary GLP-1-like state during and shortly after the viral illness
What Results Look Like for People With Hypothyroidism People with well-controlled hypothyroidism on GLP-1 medications can expect meaningful weight loss, though the pace may be modestly slower than in people without thyroid disease
(PubMed) Myint PK, Luben RN, Welch AA, Bingham SA, Wareham NJ, Khaw KT
